Stack Financial Management Inc Has $17.56 Million Holdings in Cardinal Health, Inc. $CAH

Stack Financial Management Inc lowered its stake in Cardinal Health, Inc. (NYSE:CAH) by 1.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 104,507 shares of the company’s stock after selling 1,727 shares during the period. Cardinal Health makes up approximately 1.6% of Stack Financial Management Inc’s holdings, making the stock its 26th biggest position. Stack Financial Management Inc’s holdings in Cardinal Health were worth $17,557,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Principal Financial Group Inc. lifted its position in shares of Cardinal Health by 5.3% in the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock worth $43,510,000 after buying an additional 15,956 shares during the last quarter. Kingswood Wealth Advisors LLC lifted its position in shares of Cardinal Health by 17.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company’s stock worth $429,000 after buying an additional 457 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Cardinal Health by 25.8% in the first quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company’s stock worth $1,811,000 after buying an additional 2,694 shares during the last quarter. Golden State Wealth Management LLC lifted its position in shares of Cardinal Health by 569.5% in the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock worth $54,000 after buying an additional 336 shares during the last quarter. Finally, North Capital Inc. acquired a new stake in shares of Cardinal Health in the first quarter worth about $83,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at approximately $3,881,969.70. This represents a 61.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Jason M. Hollar sold 107,705 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.90, for a total value of $16,037,274.50. Following the completion of the transaction, the chief executive officer directly owned 235,901 shares of the company’s stock, valued at approximately $35,125,658.90. The trade was a 31.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 in the last 90 days. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Stock Down 0.2%

Cardinal Health stock opened at $156.86 on Monday. The business has a 50 day moving average price of $152.09 and a two-hundred day moving average price of $151.31. The stock has a market cap of $37.27 billion, a price-to-earnings ratio of 24.32, a price-to-earnings-growth ratio of 1.33 and a beta of 0.71. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44.

Cardinal Health (NYSE:CAH) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same period in the prior year, the firm posted $1.84 EPS. Cardinal Health’s quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Evercore ISI cut their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Leerink Partners boosted their price objective on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research report on Monday, October 6th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.